The Texas Comptroller's Office has approved two Islamic private schools from North Texas to take part in the state's taxpayer‑funded school choice program. The move comes one day after Houston federal ...

Nishtha Singh uploaded a photograph of what appeared to be a school assignment sheet. The worksheet contained a set of ...

A woman shared a post about her sister learning Python and AI in Class 7, sparking debate online about early coding education ...

Florida's Python Elimination Program pays certified hunters to remove the invasive snakes from the Everglades. Burmese pythons have caused a severe decline in native small mammal populations in South ...

The EV transition might have hit a hurdle in the U.S., but it’s not slowing down in East Africa, where several startups are vying for a piece of the burgeoning electric motorbike market. Zeno is one ...

A state-funded program helping rebuild a depleted police force is in jeopardy if it does not receive more funding in this legislative session. Since launching in 2024, the Intensive Comprehensive ...

Two new pieces of economic data, one released Thursday and one released Friday, blew another hole in President Donald Trump’s triumphant narrative about the effects of his tariffs. The figures ...

Editor's note: Follow Olympics figure skating live results and updates from the 2026 Winter Games. MILAN — Day 1 of pairs' figure skating at the 2026 Winter Olympics is in the books and two U.S. pairs ...

The January portal window (standard Jan. 2–16, plus the additional five-day window for teams still playing) produced historic churn across college football. Programs across the country experienced ...

Blue Origin has “paused” its New Shepard program for the next two years, a move that likely signals a permanent end to the suborbital space tourism initiative. The small rocket and capsule have been ...

Reviews of Sanofi’s diabetes drug Tzield and Disc Medicine’s blood-disorder medicine bitopertin stalled Tzield pushed back after adverse event reports; bitopertin delayed two weeks amid efficacy and ...

Jan 15 (Reuters) - The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for the Trump administration's ‌new fast-track program after agency scientists flagged safety and ...